English
Chinese
French
Arabic
Spanish
CHU PHARMA Makes its Debut at Pharmaceutical Africa, Expanding its Market Footprint in West African French-Speaking Regions
Pharmaceutical Africa, Africa's largest professional pharmaceutical exhibition, was held in Lagos, Nigeria. CHU PHARMA sent a delegation to participate, showcasing its Vitamin C injection, calcium chloride ···
CHU PHARMA Participates in API China, Reaches Annual Foreign Trade Framework Agreement Worth Tens of Millions of Yuan
The 86th API China Autumn Exhibition concluded successfully. CHU PHARMA showcased its full range of APIs and injectable drug manufacturing solutions. During the exhibition, it signed annual supply framework agr···
ISO 9001 Quality Management System Certification Solidifies Compliance Foundation for API Exports
CHU PHARMA's entire product line successfully passed the ISO 9001 international quality management system audit and certification, establishing standardized control procedures for the entire process from ra···
New Indocyanine Green and Lidocaine Injectable APIs Added to Product Line, Enriching Export Product Matrix
The company has completed its strategic expansion of its product portfolio, officially adding commonly used injectable APIs such as indocyanine green for injection, lidocaine hydrochloride, and gentamicin sulfa···
Showcasing at CPHI China, the World's Leading Pharmaceutical Ingredient Exhibition, CHU PHARMA Expands its Market in the Middle East
The 21st CPHI China Shanghai exhibition was successfully held. CHU PHARMA focused on the Middle East's essential pharmaceutical market, highlighting its sterile injectable APIs and oral formulation contract···
First Overseas Exhibition at Vietnam VIFA International Pharmaceutical Exhibition: Deepening the Reach of Local Formulation Manufacturers in Southeast Asia
The 2020 Vietnam Ho Chi Minh City VIFA International Pharmaceutical Exhibition was successfully held, marking the company's first independent overseas participation in a professional pharmaceutical exhibiti···
CHU PHARMA and Shaanxi University of Science and Technology Reach Strategic Industry-University-Research Cooperation to Jointly Establish API Process Optimization Laboratory
CHU PHARMA and Shaanxi University of Science and Technology officially signed a long-term industry-university-research cooperation agreement. Leveraging the university's mature R&D capabilities in fine ···
CHU PHARMA Makes its Debut at API China, Secures First Batch of Overseas Potential Clients
Published: 2019-05-22 The 83rd API China (China International Pharmaceutical Ingredients Trade Fair) concluded successfully in Shanghai. This marked CHU PHARMA's first appearance at a major industry exhibit···
CHU PHARMA Officially Registered, Focusing on Core Sectors of API Export and Pharmaceutical CDMO
Recently, CHU PHARMA officially completed its business registration in Xi'an. The company focuses on "high-quality API export, customized CDMO API manufacturing, and injectable OEM production," ba···